Key result
Transcutaneous auricular vagus nerve stimulation significantly increased the high frequency component of heart rate variability compared to sham stimulation in healthy young adults.
Why the study?
Decreased heart rate variability is closely linked to morbidity and mortality across various diseases, making it important to investigate the effects of transcutaneous auricular vagus nerve stimulation on HRV.
Does transcutaneous auricular vagus nerve stimulation improve heart rate variability in healthy young people?
RCT (n=34)
Single-blind
Randomized
No
Does transcutaneous auricular vagus nerve stimulation improve heart rate variability in healthy young people?
Absolute Event Rate: 442% vs 273.1%
p-value: p=0.001
Transcutaneous auricular vagus nerve stimulation effectively increases heart rate variability in healthy young individuals, suggesting potential therapeutic utility for conditions associated with low HRV.
Hypothesis-generating in healthy youth; leaves open clinical translation or sustained effects in disease.
Transcutaneous auricular vagus nerve stimulation (taVNS) has shown positive effects on a variety of diseases. Considering that decreased heart rate variability (HRV) is closely associated with morbidity and mortality for a variety of diseases, it is important to investigate the effect of taVNS on HRV. In Study 1, we conducted a two-stage cross-over trial to compare the effects of taVNS and sham taVNS (staVNS) on HRV. In Study 2, we systematically tested the effects of different taVNS parameters on high frequency (HF) component of HRV. The results showed that taVNS significantly increased measurements of root mean square of the difference between successive RR intervals (RMSSD), percentage of number of pairs of adjacent RR intervals differing greater than 50ms (pRR50), standard deviation of all RR intervals (SDRR), HF. Significantly, enhancement of HF and pRR50 persisted into recovery period. In addition, higher baseline LF/HF ratio was associated with greater LF/HF ratio decrease. Findings also showed that there was no significant difference in measurements of HF between different taVNS parameters. These studies suggest that taVNS could increase HRV, it may help taVNS in the treatment of low HRV related diseases. However, taVNS may not have parameter-specific effects on HRV.
No takes yet. Share an insight, caveat, or question.
Geng et al. (2022) conducted an RCT in Healthy (n=34). Transcutaneous auricular vagus nerve stimulation (taVNS) vs. Sham taVNS (staVNS) at the earlobe was evaluated on High frequency (HF) component of heart rate variability (p=0.001). Transcutaneous auricular vagus nerve stimulation significantly increased the high frequency component of heart rate variability compared to sham stimulation in healthy young adults.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: